Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
- No manufacturer-published in-use stability past "conservative 14 days refrigerated." - Lyophilized powder quality varies by supplier
Retatrutide is an investigational triple-hormone receptor agonist developed by Eli Lilly that targets three receptors: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon
Syringe Units = Volume to Draw (mL) 100 = 0.1 mL 100 = 10 units GHK-Cu Dosing Profile (50 mg Vial / 2.5 mL BAC Water) 1 mg Dose: Draw 5 units (0.05 mL)
BPC-157 (Body Protection Compound-157) Purported Benefits: Accelerated wound healing Reduced inflammation Improved joint and gut health Potential Risks and Complications: Unknown Long-Term Effects: With limited human studies, the long-term impact on organs and systems is unknown
At least 60% of circulating vitamin B 6 corresponds to pyridoxal phosphate
For optimal results, we typically combine B12 injections with other evidence-based SAD interventions such as light therapy and appropriate physical activity
US$ 27.94
US$ 22.44
US$ 24.84
US$ 22.54
US$ 21.99
US$ 22.47
US$ 25.61
